Persistent increase in the motivation to take heroin in rats with a history of drug escalation

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
S H AhmedG F Koob

Abstract

The transition from stable to escalated levels of cocaine self-administration has been shown to depend upon drug availability. The generality of this phenomenon is assessed here by studying the effects of availability on heroin self-administration. Two groups of rats were trained on a 1-h continuous schedule of self-administration, after which, access to heroin (40 microg/injection) was increased to 11 h in one group (long access or LgA rats) or kept to 1 h in the other group (short access or ShA rats). After 18 sessions on this regimen, both ShA and LgA rats were tested for extinction and stress-induced reinstatement of heroin-seeking behavior. In LgA rats, both total and first hour intake gradually escalated over time. After escalation, LgA rats were slower to extinguish heroin-seeking behavior and responded more to the reinstating effect of stress after extinction. These findings show that: (1) the escalation process in drug consumption is common to both opiate and stimulant self-administration; (2) escalation in heroin consumption is associated with a persistent increase in the motivation for taking heroin.

Citations

Mar 23, 2006·Psychopharmacology·Osamu KitamuraLuigi Pulvirenti
Mar 17, 2004·Neuroscience and Biobehavioral Reviews·George F KoobPietro Paolo Sanna
Jun 12, 2013·Neuropharmacology·George F KoobOlivier George
Jun 14, 2002·Pharmacology, Biochemistry, and Behavior·Andrew D MorganMarilyn E Carroll
Jan 25, 2003·Pharmacology, Biochemistry, and Behavior·Suzette M EvansRichard W Foltin
Jul 23, 2003·Pharmacology, Biochemistry, and Behavior·John R WalkerGeorge F Koob
Sep 3, 2002·Neuroscience and Biobehavioral Reviews·Tangui MauriceRae R Matsumoto
Sep 1, 2000·Brain Research. Brain Research Reviews·Y ShahamJ Stewart
Jan 12, 2002·Peptides·A L Vaccarino, A J Kastin
Jun 14, 2003·Behavioral Neuroscience·Sara B Lattanzio, Roelof Eikelboom
Aug 23, 2003·Behavioral Neuroscience·Roelof Eikelboom, Sara B Lattanzio
Dec 25, 2002·Experimental and Clinical Psychopharmacology·Francesco Leri, Jane Stewart
Jun 16, 2010·Experimental and Clinical Psychopharmacology·Julie A MarusichMichael T Bardo
Dec 27, 2006·Nature Neuroscience·Brandon K HarveyYavin Shaham
Jan 16, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Christopher M Olsen, Danny G Winder
Aug 28, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·George F Koob, Nora D Volkow
Dec 17, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Lei WangLan Ma
Dec 15, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Carmela M ReichelRonald E See
Jun 18, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Xinchun JinAthina Markou
Sep 13, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Sietse Jonkman, Paul J Kenny
Jan 11, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Estelle BarbierMarkus Heilig
May 3, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ami CohenOlivier George
Jan 17, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Magalie LenoirSerge H Ahmed
Jun 2, 2009·Nature Reviews. Drug Discovery·George F KoobBarbara J Mason
Jul 22, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Serge H Ahmed, Martine Cador
Sep 30, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Paul J Kenny, Athina Markou
Feb 3, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Scott A ChenGeorge F Koob
Mar 17, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Scott EdwardsDavid W Self

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.